72.11.Z - Scientific research and development activities
64.19.Z - Other monetary intermediation
64.92.Z - Other forms of credit granting
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
66.21.Z - Risk assessment and loss estimation activities
70.10.Z - Head office activities
70.22.Z - Head office activities and management consultancy
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,9 | -1,9 | -2,1 | -11,1 |
EBITDA | -1,9 | -2 | -1,9 | 1,1 |
Short time liabilities | 0,4 | 1,3 | 0,3 | -78,1 |
Equity capital | 7,9 | 8,3 | 27,4 | 229,3 |
Operating profit (EBIT) | -1,9 | -2 | -1,9 | 0,9 |
Assets | 8,3 | 9,7 | 27,7 | 185,9 |
Net profit (loss) | -1,9 | -1,9 | -2,1 | -11,1 |
Cash | 1,6 | 0 | 4,9 | 11 313,5 |
Net income from sale | 0 | 0 | 0 | -100 |
Liabilities and provisions for liabilities | 0,4 | 1,4 | 0,3 | -77,9 |
Working assets | 2,5 | 1,9 | 7,9 | 311,4 |
Depreciation | 0 | 0 | 0 | 45,5 |
% | % | % | p.p. | |
Profitability of capital | -23,9 | -22,4 | -7,6 | 14,8 |
Equity capital to total assets | 94,6 | 85,9 | 98,9 | 13 |
Gross profit margin | -9114,9 | |||
EBITDA Margin | -9576,7 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 23 597 | 2 147 483 648 | 2 147 460 051 |
Current financial liquidity indicator | 5.452002048492432 | 1.4567723274230957 | 27.393396377563477 | 25,9 |
Net dept to EBITDA | 0.8507493734359741 | -0.10601432621479034 | 2.504127025604248 | 2,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane